CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 45 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-16 | RA CAPITAL MANAGEMENT, L.P. Director | Purchase · Pre-Funded Warrants (Right to Buy) | +7,093,656 | $2.15 | $15.3M | 7,093,656 |
| 2022-05-05 | Vargeese Chandra | Sale | −16,714 | $1.72 | $29K | 111,095 |
| 2022-05-05 | BOLNO PAUL President and CEO | Sale | −33,501 | $1.72 | $58K | 436,825 |
| 2022-05-05 | Moran Kyle Chief Financial Officer | Sale | −5,021 | $1.72 | $9K | 84,567 |
| 2022-05-05 | Panzara Michael A. | Sale | −16,714 | $1.72 | $29K | 109,103 |
| 2022-05-05 | Francis Chris | Sale | −10,867 | $1.72 | $19K | 89,972 |
| 2022-05-04 | Vargeese Chandra | Grant or award | +50,000 | 127,809 | ||
| 2022-05-04 | BOLNO PAUL President and CEO | Grant or award | +92,500 | 470,326 | ||
| 2022-05-04 | Moran Kyle Chief Financial Officer | Grant or award | +15,000 | 89,588 | ||
| 2022-05-04 | Panzara Michael A. | Grant or award | +50,000 | 125,817 | ||
| 2022-05-04 | Francis Chris | Grant or award | +32,500 | 100,839 | ||
| 2022-02-16 | Moran Kyle Chief Financial Officer | Sale | −9,204 | $2.31 | $21K | 74,588 |
| 2022-02-16 | Francis Chris | Sale | −10,123 | $2.31 | $23K | 68,339 |
| 2022-02-16 | Vargeese Chandra Chief Technology Officer | Sale | −10,603 | $2.32 | $25K | 77,809 |
| 2022-02-16 | BOLNO PAUL President and CEO | Sale | −33,150 | $2.32 | $77K | 377,826 |
| 2022-02-16 | Panzara Michael A. | Sale | −10,603 | $2.31 | $24K | 75,817 |
| 2022-01-01 | Moran Kyle Chief Financial Officer | Grant or award · Share Option (right to buy) | +175,000 | 175,000 | ||
| 2022-01-01 | Panzara Michael A. | Grant or award · Share Option (right to buy) | +200,000 | 200,000 | ||
| 2022-01-01 | BOLNO PAUL | Grant or award · Share Option (right to buy) | +600,000 | 600,000 | ||
| 2022-01-01 | Francis Chris | Grant or award · Share Option (right to buy) | +150,000 | 150,000 |
Page 14 of 22 · 433 trades